Biotech industry leaders share cautious optimism for 2023 amid downturn and layoffs Sujal Patel has been here before. He weathered the 2009 recession as CEO of Isilon Systems, coming out the other… Read More
Life sciences news roundup: COVID-19 vaccines developed in Seattle get green light, and more Two COVID-19 vaccines developed in Seattle got the nod from regulatory agencies outside the U.S. this week. A University of… Read More
Life Sciences News: Manufacturing facilities in Spokane and Seattle area; deals, funding, and more Here’s a rundown of the top life sciences and health news across the Pacific Northwest this week. Sana Biotechnology will… Read More
Life sciences news: Seattle researchers make Time list; ‘blowing apart’ academic promotion; and more It was a week of accolades, partnerships and new programs in the Pacific Northwest life sciences scene. University of Washington… Read More
Juno’s lasting legacy: How the cell therapy juggernaut influenced biotech in Seattle and beyond When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of… Read More
Bristol Myers Squibb and Century Therapeutics’ deal for $150M could boost Seattle cell research Cell therapy company Century Therapeutics will receive a $100 million up front payment and $50 million in equity investment from… Read More
Bristol Myers Squibb exec on the company’s growth in Seattle and beating cancer with immune cells Pharmaceutical giant Bristol Myers Squibb has been quietly growing in the Seattle area. Since acquiring Celgene and its Seattle operations… Read More
